Compare HDSN & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HDSN | LAB |
|---|---|---|
| Founded | 1991 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 409.2M | 449.9M |
| IPO Year | 1994 | 2011 |
| Metric | HDSN | LAB |
|---|---|---|
| Price | $7.36 | $1.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $9.50 | $1.35 |
| AVG Volume (30 Days) | 484.2K | ★ 2.0M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $236,847,000.00 | $169,737,000.00 |
| Revenue This Year | $2.65 | N/A |
| Revenue Next Year | $3.69 | N/A |
| P/E Ratio | $14.85 | ★ N/A |
| Revenue Growth | N/A | ★ 79.77 |
| 52 Week Low | $5.11 | $0.92 |
| 52 Week High | $10.52 | $2.25 |
| Indicator | HDSN | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 66.31 |
| Support Level | $6.88 | $1.44 |
| Resistance Level | $7.62 | $1.51 |
| Average True Range (ATR) | 0.27 | 0.08 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 62.04 | 84.21 |
Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.